Top 5 Undervalued Stocks To Watch Right Now


I came across NetEase (NASDAQ:NTES) in early 2013, when it was starting to become a major player in the Chinese mobile game industry. At first, I was a bit skeptical about their future growth and valuation. Video game companies are sometimes “one-hit wonders”, and decline after their top sellers lose popularity. But NetEase is an exception. After watching it for a few months, I decided then to bite the bullet and buy the stock. And I’m glad I did.

The company has produced leading online games in China since 2001, has a diversified business model over many in-house developed and licensed titles, and currently holds over $4.6 billion in cash, which can be used for buybacks, dividends and acquisitions.


I believe that NTES is still significantly undervalued and there are several upcoming catalysts which will unlock this value. The company is a dominant player in the Chinese gaming market, with significant competitive advantages and high barriers to entry.

Basic information

Top 5 Undervalued Stocks To Watch Right Now: Western Asset High Income Opportunity Fund, Inc.(HIO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Western Asset High Income (NYSE:HIO) have been trending positive this week, according to Accern Sentiment. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Western Asset High Income earned a coverage optimism score of 0.49 on Accern’s scale. Accern also assigned press coverage about the closed-end fund an impact score of 47.4682522681889 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Ethan Ryder]

    Media headlines about Western Asst High Incm Opprtnty Fnd (NYSE:HIO) have trended positive on Monday, according to Accern. Accern ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Western Asst High Incm Opprtnty Fnd earned a news impact score of 0.36 on Accern’s scale. Accern also gave media stories about the closed-end fund an impact score of 46.8812467861134 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 5 Undervalued Stocks To Watch Right Now: Northfield Bancorp Inc.(NFBK)


Advisors’ Opinion:

  • [By Joseph Griffin]

    Northfield Bancorp (NASDAQ: NFBK) and 1st Constitution Bancorp (NASDAQ:FCCY) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

  • [By Shane Hupp]

    Shares of Northfield Bancorp Inc. (NASDAQ:NFBK) have received a consensus recommendation of “Hold” from the eight brokerages that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $17.50.

  • [By Logan Wallace]

    These are some of the news stories that may have impacted Accern Sentiment’s scoring:

    Get Northfield Bancorp alerts:

    Head-To-Head Contrast: Northfield Bancorp (NFBK) & The Competition (americanbankingnews.com) Northfield Bancorp (NFBK) and Its Competitors Critical Survey (americanbankingnews.com) Head to Head Survey: Northfield Bancorp (NFBK) versus The Competition (americanbankingnews.com) Northfield Bancorp (NFBK) Stock Rating Lowered by BidaskClub (americanbankingnews.com) Northfield Bancorp (NFBK) & Its Rivals Head to Head Analysis (americanbankingnews.com)


    Shares of Northfield Bancorp opened at $15.96 on Thursday, MarketBeat reports. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.71. Northfield Bancorp has a twelve month low of $15.88 and a twelve month high of $15.92. The firm has a market capitalization of $777.27 million, a P/E ratio of 21.86, a price-to-earnings-growth ratio of 2.37 and a beta of 0.35.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Northfield Bancorp (NASDAQ:NFBK) from a hold rating to a buy rating in a research note released on Saturday morning.


    Other equities analysts also recently issued reports about the stock. TheStreet raised shares of Northfield Bancorp from a c+ rating to a b rating in a research note on Thursday, April 26th. ValuEngine downgraded shares of Northfield Bancorp from a hold rating to a sell rating in a research note on Tuesday, June 12th. Zacks Investment Research downgraded shares of Northfield Bancorp from a buy rating to a hold rating in a research note on Thursday, May 17th. Finally, Keefe, Bruyette & Woods reaffirmed a hold rating and set a $18.50 target price on shares of Northfield Bancorp in a research note on Tuesday, February 27th. Six analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Northfield Bancorp presently has an average rating of Hold and an average price target of $17.60.

  • [By Shane Hupp]

    Northfield Bancorp (NASDAQ: NFBK) is one of 90 publicly-traded companies in the “Federal savings institutions” industry, but how does it weigh in compared to its peers? We will compare Northfield Bancorp to related companies based on the strength of its dividends, profitability, risk, institutional ownership, valuation, analyst recommendations and earnings.

Top 5 Undervalued Stocks To Watch Right Now: Primerica, Inc.(PRI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Wells Fargo & Company MN boosted its stake in Primerica (NYSE:PRI) by 2.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 838,510 shares of the financial services provider’s stock after purchasing an additional 19,142 shares during the quarter. Wells Fargo & Company MN’s holdings in Primerica were worth $81,000,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Great Lakes Advisors LLC bought a new position in shares of Primerica (NYSE:PRI) in the first quarter, according to the company in its most recent filing with the SEC. The firm bought 6,834 shares of the financial services provider’s stock, valued at approximately $660,000.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Joseph Griffin]

    Primerica (NYSE:PRI) has been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating. The average 1-year target price among brokers that have issued a report on the stock in the last year is $103.00.

Top 5 Undervalued Stocks To Watch Right Now: Home Federal Bancorp Inc.(HOME)

Advisors’ Opinion:

  • [By Logan Wallace]

    TRADEMARK VIOLATION WARNING: “Positive News Coverage Somewhat Unlikely to Affect At Home (HOME) Stock Price” was published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3356638/positive-news-coverage-somewhat-unlikely-to-affect-at-home-home-stock-price.html.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on At Home Group (HOME)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    At Home Group (NYSE:HOME) issued an update on its second quarter earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.32-0.33 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.28. The company issued revenue guidance of $284-287 million, compared to the consensus revenue estimate of $283.98 million.At Home Group also updated its FY19 guidance to $1.25-1.30 EPS.

  • [By Joseph Griffin]

    At Home Group (NYSE:HOME) updated its FY19 earnings guidance on Thursday. The company provided earnings per share guidance of $1.25-1.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.23. The company issued revenue guidance of $1.15-1.16 billion, compared to the consensus revenue estimate of $1.16 billion.At Home Group also updated its Q2 guidance to $0.32-0.33 EPS.

  • [By ]

    Real Money columnist Robert Lang says that while retail “has certainly had its challenges over the past couple of years, between difficulties in the mall and then the big gorilla in the room, Action Alerts PLUS holding Amazon (AMZN) …there are a handful of names that continue to perform well, one of those is At Home Group (HOME) .

Top 5 Undervalued Stocks To Watch Right Now: ADMA Biologics Inc(ADMA)


Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get ADMA Biologics alerts:

    Global Drugs for Respiratory Syncytial Virus (RSV) Market 2018 Insights- Ablynx, AmVac, AlphaVax and ADMA Biologics (exclusivereportage.com) Global Drugs for Respiratory Syncytial Virus (RSV) Market 2018 View- ADMA Biologics, Ablynx, AlphaVax and AmVac (exclusivereportage.com) After-Hours Stock Movers 06/07: (ZUMZ) (DOCU) (SFIX) Higher; (MVIS) (ITI) (ADMA) Lower (more…) (streetinsider.com) Why is the 200 Simple Moving Average (SMA) so common for traders and analysts? Build-A-Bear Workshop, Inc … (thestreetpoint.com) Global Lupus Therapeutic Market 2018 by Players: ADMA Biologics, Amgen, Anthera Pharma, Bayer HealthCare (ebuzzcommunity.com)

    ADMA has been the subject of a number of analyst reports. Maxim Group set a $10.00 price objective on shares of ADMA Biologics and gave the stock a “buy” rating in a report on Monday, May 14th. ValuEngine raised shares of ADMA Biologics from a “sell” rating to a “hold” rating in a report on Monday, May 14th.

  • [By Max Byerly]

    Maxim Group set a $10.00 price objective on ADMA Biologics (NASDAQ:ADMA) in a report issued on Monday. The brokerage currently has a buy rating on the biotechnology company’s stock.

  • [By Joseph Griffin]

    Media stories about ADMA Biologics (NASDAQ:ADMA) have trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ADMA Biologics earned a news impact score of 0.03 on Accern’s scale. Accern also assigned press coverage about the biotechnology company an impact score of 45.3142660303953 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.